Sanofi nabs FDA approval for Menactra booster; AZ's new Bydureon pen rolls out; Par restarts generic Precedex shipments;

@FiercePharma: Top-read on FP Monday: Bristol-Myers socks Merck's brand-new Keytruda with PD-1 patent suit. Article | Follow @FiercePharma

@EricPFierce: ICYMI yesterday: Action against AbbVie, Teva over AndroGel comes as FTC is stalking a $1B settlement this year. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Latest Allergan buzz puts Ireland's Jazz in its dealmaking sights. Story | Follow @CarlyHFierce

> Sanofi Pasteur won FDA approval for its Menactra vaccine as a booster shot against meningococcal disease in 15- to 55-year-olds. Release

> AstraZeneca ($AZN) said its new Bydureon pen for Type 2 diabetes is now available in the U.S. Report

> Par Pharmaceutical resumed shipping its version of Hospira's ($HSP) sedative Precedex after a U.S. court lifted a restraining order against the launch. Release

> A Washington, DC, federal judge refused to allow the consumer watchdog Public Citizen to access documents related to off-label marketing settlements involving Pfizer ($PFE) and Purdue Pharma. Report (reg. req.)

> Novartis ($NVS) sued two Indian drugmakers for patent infringement, targeting Zydus Pharmaceuticals' plans for a generic version of its Alzheimer's treatment, Exelon Patch, and Dr. Reddy's Laboratories' effort to knock off its cancer drug Gleevec. Report | Report

> U.S. Treasury Secretary Jack Lew called for quick action against tax inversion deals, such as AbbVie's ($ABBV) planned buyout of Shire ($SHPG). Report

> Pfizer Canada donated EpiPen injectors as part of a pilot project aimed at making the anaphylaxis-fighter available at every restaurant and food court in Hamilton, Ontario. Report

Medical Device News

@FierceMedDev: GE Healthcare, FBI allege Chinese engineer stole MRI trade secrets. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: EU creates €1B fund for research on the use of graphene. Article | Follow @VarunSaxena2

@MichaelGFierce: ICYMI: UO, Berkeley team tailors ultrathin peptoid nanosheets for delivery using oil and water. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: J&J ordered to fork over $3.27M in vaginal mesh case. Report | Follow @EmilyWFierce

> Israeli startup develops hand-held device for medical marijuana. Report

> Titan Spine offers first spine implant warranty. More

> Stent developer Tryton gets $20M to complete FDA submission, market in EU. Story

Biotech News

@FierceBiotech: Christoph Westphal launches another biotech, with the help of some wealthy friends. Story | Follow @FierceBiotech

@JohnCFierce: Can Novo Nordisk and Orexigen finally open up a blockbuster weight-loss market? More | Follow @JohnCFierce

@DamianFierce:   | Follow @DamianFierce

@EmilyMFierce: Great tool for journalists covering NIH budget: @UMR4NIH launched an interactive map that breaks down state funding. More | Follow @EmilyMFierce

> OrbiMed Advisors banks $325M for a new round of Asian biotech bets. Report

> Boehringer's next-gen COPD treatment hits the mark in Phase III. Article

> PRA lines up a $375M IPO after a string of CRO deals. Story

Biotech Research News

> Compound inhibits both MERS, SARS. Report

> Experimental C. difficile drugs could be more effective than current therapy. Article

> Glaxo's Ebola vaccine effective in monkeys but may require booster shot. More

> 'Disease in a dish' aids Huntington's drug discovery. Item

> Scientists find way to expand blood stem cell production in lab. Story

Pharma Manufacturing News

> ProBioGen will double its Berlin staff to expand cell-based manufacturing. Article

> Germany's Aenova buys North Carolina packaging operation. Item

> Cipla buys two Indian manufacturing facilities for partner Okasa. Story

> Perrigo recalls 367,000 tubes of nicotine lozenges. Report

> FDA, DOJ arrest NECC pharmacist about to leave the country. Article

And Finally... Health officials identified an unusual, serious outbreak of enterovirus in children in the Midwest. Report